Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
L01XC32
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
574817
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
619317
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
792320
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
769320
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
541216
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
||
|
FDA ORPHAN DRUG |
550616
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
||
|
NDF-RT |
N0000191260
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
||
|
NCI_THESAURUS |
C128057
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL3707227
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
Atezolizumab
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
DB11595
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
Atezolizumab
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
100000163921
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
C106250
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
SUB178312
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
N0000011175
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | Antibodies [Chemical/Ingredient] | ||
|
N0000183512
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | Antibodies, Monoclonal, Humanized [Chemical/Ingredient] | ||
|
52CMI0WC3Y
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
9814
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
0INE2SFD9E
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
52CMI0WC3Y
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
1380723-44-3
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
CD-146
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
1792776
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
5151
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
1422185-06-5
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
NO STRUCTURE GIVEN | |||
|
m11954
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
N0000191259
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | Programmed Death Receptor-1-directed Antibody Interactions [MoA] |
ACTIVE MOIETY